HT BioImaging (HTVet)

HT BioImaging (HTVet) is a cutting-edge medical imaging company founded in 2015 in Israel. The company has developed a revolutionary medical imaging modality that is not only accurate and immediate, but also 100% safe for early cancer detection. Their subsidiary, HTVet, focuses on the veterinary market, offering HT Vista, a pioneering non-invasive medical device. This technology allows veterinarians to quickly rule out cancer in the clinic, providing on-the-spot results. The potential of this innovation is exemplified by the recent Venture Round investment led by NextLeap Ventures, EIT Health, and Magna Capital Partners in July 2020. For more information, please visit HTVet.